Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00045773 · ClinicalTrials.gov registry record
Treatment Outcome of Vascular Depression
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 208
- Enrollment target
NCT00045773 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 208 participants.
The verdict
NCT00045773 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
This 12-week study will evaluate the effectiveness of sertraline (Zoloft®) for treatment of depression associated with small vascular lesions in the brain (vascular depression).
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2001-04 |
| Est. Completion | 2006-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00045773
The ClinicalTrials.gov registry entry for NCT00045773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT00045773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00045773 about?
NCT00045773 is a clinical study titled "Treatment Outcome of Vascular Depression". This 12-week study will evaluate the effectiveness of sertraline (Zoloft®) for treatment of depression associated with small vascular lesions in the brain (vascular depression).
What is the current status of trial NCT00045773?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2001-04. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00045773?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT00045773?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.